期刊文献+

ICU医院获得性肺炎感染病原菌耐药性及危险因素分析 被引量:15

Analysis of pathogen resistance and risk factors in ICU hospitalized patients with HAP
下载PDF
导出
摘要 目的探讨ICU医院获得性肺炎(HAP)感染病原菌特点及其耐药性,分析ICU住院患者发生HAP的相关危险因素,为临床治疗HAP提供依据。方法回顾性分析2011年12月至2015年2月我院收治的405例ICU住院患者的临床资料,分析其病原菌分布、主要病原菌耐药性,单因素及多因素Logistic回归分析ICU住院患者发生HAP的相关危险因素。结果 405例ICU住院患者发生HAP 146例,感染率为36.05%,共检出病原菌184株,其中革兰阴性菌、阳性菌、真菌各125、48、11株,各占67.93%、26.09%、5.98%;金黄色葡萄球菌、肺炎链球菌对万古霉素的耐药率较低;单因素及多因素Logistic回归分析发现,应用镇静药物、入ICU时间>7 d、入ICU前后进行手术是ICU住院患者发生HAP的独立危险因素(P<0.05)。结论 ICU HAP患者感染病原菌较广,发生HAP的相关危险因素较多,需采取相应措施,合理选用抗菌药物,以降低耐药率及医院感染率。 Objective To explore the characteristics and drug resistance of pathogenic bacteria in ICU hospitalized patients with hospital acquired hospital-acquired pneumonia( HAP),and to analyze the relevant risk factors,in order to provide basis for the clinical treatment of HAP. Methods A total of 405 ICU hospitalized patients from December 2011 to February 2015 in our hospital were selected and the clinical data was retrospectively analyzed. The distribution of pathogens and the main pathogen resistance was analyzed. The related risk factors in ICU hospitalized patients with HAP were analyzed by univariate and multivariate logistic regression analysis. Results Totally 146 patients acquired HAP among 405 ICU hospitalized patients,infection rate being 36. 05%; 184 pathogens were detected,including gram-negative bacteria,positive bacteria and fungi being 125,48 and 11 strains,which accounted for 67. 93%,26. 09% and 5. 98%. The resistance of Staphylococcus aureus and Streptococcus pneumoniae to vancomycin was low.The univariate and multivariate logistic regression analysis found that the use of sedative drugs,the ICU time 〉7 d and patients receiving surgery were independent risk factor( P〈0. 05) in ICU hospitalized patients. Conclusion ICU hospitalized patients infected with broad pathogens and related risk factors of HAP are abundant. Appropriate measures should be taken and rational use of antimicrobial drugs should be made to reduce resistance rates and hospital infection rates.
出处 《实用药物与临床》 CAS 2016年第3期367-370,共4页 Practical Pharmacy and Clinical Remedies
基金 2011年浙江省医院可持续发展扬子江研究基金项目(2011ZHA-YZJ312)
关键词 ICU 医院获得性肺炎 耐药性 危险因素 ICU Hospital-acquired pneumonia Resistance Risk factors
  • 相关文献

参考文献9

二级参考文献91

  • 1戴春梅,周建党,伍勇,漆涌.重症监护病房医院感染病原菌分布及其耐药性分析[J].中南大学学报(医学版),2006,31(2):277-280. 被引量:28
  • 2罗百灵,王丽静,胡成平,戴文鑫.1995-2004年下呼吸道感染病原菌变迁[J].中国感染与化疗杂志,2006,6(3):182-185. 被引量:34
  • 3杜小幸,张幸国,周华,俞云松,陈亚岗,李兰娟.亚胺培南耐药鲍曼不动杆菌同源性及碳青霉烯酶研究[J].中国感染与化疗杂志,2006,6(4):231-235. 被引量:47
  • 4陈灏珠.实用内科学[M].北京:人民卫生出版社,2009.
  • 5中国人民共和国卫生部医政司.全国临床检验操作规程[M].3版.南京:东南大学出版社,2006:246-266.
  • 6American Thoracic Society.Guidelines for the management ofadults with hospital-acquired,ventilator associated,andhealthcare-associated pneumonia[J].Am J Respir Crit CareMed,2005,171:388-416.
  • 7Joseph P.Lynch III.Hospital-Acquired Pneumonia:Risk Fac-tors,Microbiology,and Treatment[J].Chest,2001,119:373S-384S.
  • 8Antoni Torres,Miquel Ferrer,and Joan Ramo?n Badia.Treat-ment Guidelines and Outcomes of Hospital-Acquired and Ventila-tor-Associated Pneumonia[J].Clinical Infectious Diseases,2010,51(S1):S48-S53.
  • 9Sopena N,SabriàM,Neunos 2000Study Group.Multicenterstudy of hospital-acquired pneumonia in non-ICU patients[J].Chest,2005,127(1):213-219.
  • 10Costa D, Toledo A, Silva A B, et al. Influence of noninvasive ventilation by BiPAP on exercise tolerance and respiratory muscle strength in chronic obstructive pulmonary disease pa- tients (COPD)[J]. Rev Lat Am Enfermagem, 2006,14 (3) 378 - 382.

共引文献131

同被引文献133

引证文献15

二级引证文献107

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部